Market revenue in 2021 | USD 545.3 million |
Market revenue in 2028 | USD 890.7 million |
Growth rate | 7.3% (CAGR from 2021 to 2028) |
Largest segment | Resting ecg systems |
Fastest growing segment | ECG Management System |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Resting ECG Systems, Holter Monitoring Systems, Stress ECG Monitors, Event Monitoring Systems, ECG Management System |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Nihon Kohden Corp, CompuMed Inc, Koninklijke Philips NV, McKesson Corp, Draegerwerk AG & Co KGaA, CardioComm Solutions Inc, Hill-Rom, Mindray Medical International, BioTelemetry, SCHILLER, Spacelabs Healthcare, Device Technologies Australia, ZOLL Medical Corporation, Medical Econet, Meditech |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ecg equipment and management systems market will help companies and investors design strategic landscapes.
Resting ecg systems was the largest segment with a revenue share of 61.71% in 2021. Horizon Databook has segmented the China ecg equipment and management systems market based on resting ecg systems, holter monitoring systems, stress ecg monitors, event monitoring systems, ecg management system covering the revenue growth of each sub-segment from 2016 to 2028.
Availability of various products in the market due to the presence of a number of regional and multinational players, large geriatric population, and high incidence & prevalence of CVDs, stroke, & AFib are factors likely to drive the ECG equipment and management systems market in China.
As per WHO, CVDs are a leading cause of death in China and account for 3 million deaths annually; CVD events such as stroke and ischemic heart disease are anticipated to increase by 50% from 2010 to 2030. According to Beyond the Burden
The Impact of Atrial fibrillation in Asia Pacific, about 7.6 million people are suffering from AFib in China. 1 in every 5 adults in China is estimated to be at risk of developing AFib in their lifetime. Some of the key companies operating in China.
Horizon Databook provides a detailed overview of country-level data and insights on the China ecg equipment and management systems market , including forecasts for subscribers. This country databook contains high-level insights into China ecg equipment and management systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account